The aim of this review is to summarize the current research on the levels of steroids and biosynthetic enzymes in the AD brain and their relationship with critical pathogenic factors in various AD models, including human neuroblastoma cell lines, rats and transgenic mice developing Aβ or tau pathology. This evidence concerns the gene MAPT and neuroblastoma.